Evaluation of Metabolic Labeling for Comparative Proteomics in Breast Cancer Cells
- 19 August 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 3 (5) , 1063-1068
- https://doi.org/10.1021/pr049906k
Abstract
Protein expression patterns in the cytosol of MCF-7 cells resistant to adriamycin and to adriamycin/verapamil were compared to that of the parental MCF-7 cell line and to each other using metabolic labeling and two-dimensional gel electrophoresis. Growing the parental MCF-7 cell line in 13C6-arginine- and 13C6-lysine-enriched medium resulted in C-terminal labeling of all tryptic peptides. The culture media was optimized for the incorporation of these labeled amino acids under conditions that also supported cell growth. Protein abundances were found to be distinctive in MCF-7 cells resistant to adriamycin and those selected for resistance to both adriamycin and verapamil.Keywords
This publication has 11 references indexed in Scilit:
- Proteomic phenotyping: metastatic and invasive breast cancerCancer Letters, 2004
- Multidrug-Resistant MCF-7 Cells: An Identity Crisis?JNCI Journal of the National Cancer Institute, 2002
- Differential Protein Expression in the Cytosol Fraction of an MCF-7 Breast Cancer Cell Line Selected for Resistance toward MelphalanJournal of Proteome Research, 2002
- Quantitative Analysis of the Yeast Proteome by Incorporation of Isotopically Labeled LeucineJournal of Proteome Research, 2002
- Minimizing Resolution of Isotopically Coded Peptides in Comparative ProteomicsJournal of Proteome Research, 2002
- Global internal standard technology for comparative proteomicsJournal of Chromatography A, 2002
- Re: Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic ReviewJNCI Journal of the National Cancer Institute, 2000
- A multidrug resistance transporter from human MCF-7 breast cancer cellsProceedings of the National Academy of Sciences, 1998
- Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen.JNCI Journal of the National Cancer Institute, 1998
- Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalanBritish Journal of Cancer, 1993